Eligibility of patients with type 2 diabetes for sodium‐glucose co‐transporter‐2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry

Generalizability of findings from cardiovascular outcomes trials (CVOTs) to patients with type 2 diabetes (T2D) in clinical practice is unknown. We assessed the proportions of patients in the Diabetes Collaborative Registry who would have met enrolment criteria for pivotal CVOTs of sodium‐glucose co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wittbrodt, Eric, Chamberlain, David, Arnold, Suzanne V., Tang, Fengming, Kosiborod, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767768/
https://www.ncbi.nlm.nih.gov/pubmed/30968543
http://dx.doi.org/10.1111/dom.13738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767768/
https://www.ncbi.nlm.nih.gov/pubmed/30968543
http://dx.doi.org/10.1111/dom.13738

Ejemplares similares